U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540494) titled 'Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects' on April 01.
Brief Summary: The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aerosol delivery device in healthy subjects after single-dose administration.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Intervention:
DRUG: 5 Methoxy N,N Dimethyltryptamine
GH001 administered via inhalation
DEVICE: GH001 Aerosol Delivery System
GH001 aerosol delivery system
Recruitment Status: NOT_YE...